AUG 18, 2026 · PHASE 1 TRIAL
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
ClinicalTrials.gov
This is a Phase 1 drug–drug interaction study still recruiting, with no results posted; it measures pharmacokinetic surrogates in a small healthy population and cannot yet inform clinical practice.
Reported
Planned enrollment50
Study phasePhase 1
Primary outcome measuresAUCinf, AUClast, Cmax, tmax, and t1/2λz of…